Title: Paclitaxel loading in cationic liposome vectors is enhanced by replacement of oleoyl with linoleoyl tails with distinct lipid shapes

Journal Article · · Scientific Reports

Abstract Lipid carriers of hydrophobic paclitaxel (PTX) are used in clinical trials for cancer chemotherapy. Improving their loading capacity requires enhanced PTX solubilization. We compared the time-dependence of PTX membrane solubility as a function of PTX content in cationic liposomes (CLs) with lipid tails containing one (oleoyl; DOPC/DOTAP) or two (linoleoyl; DLinPC/newly synthesized DLinTAP) cis double bonds by using microscopy to generate kinetic phase diagrams. The DLin lipids displayed significantly increased PTX membrane solubility over DO lipids. Remarkably, 8 mol% PTX in DLinTAP/DLinPC CLs remained soluble for approximately as long as 3 mol% PTX (the solubility limit, which has been the focus of most previous studies and clinical trials) in DOTAP/DOPC CLs. The increase in solubility is likely caused by enhanced molecular affinity between lipid tails and PTX, rather than by the transition in membrane structure from bilayers to inverse cylindrical micelles observed with small-angle X-ray scattering. Importantly, the efficacy of PTX-loaded CLs against prostate cancer cells (their IC50 of PTX cytotoxicity) was unaffected by changing the lipid tails, and toxicity of the CL carrier was negligible. Moreover, efficacy was approximately doubled against melanoma cells for PTX-loaded DLinTAP/DLinPC over DOTAP/DOPC CLs. Our findings demonstrate the potential of chemical modifications of the lipid tails to increase the PTX membrane loading while maintaining (and in some cases even increasing) the efficacy of CLs. The increased PTX solubility will aid the development of liposomal PTX carriers that require significantly less lipid to deliver a given amount of PTX, reducing side effects and costs.

Research Organization:
Univ. of California, Santa Barbara, CA (United States)
Sponsoring Organization:
USDOE Office of Science (SC), Basic Energy Sciences (BES); USDOE Office of Science (SC), Basic Energy Sciences (BES). Materials Sciences & Engineering Division
Grant/Contract Number:
FG02-06ER46314
OSTI ID:
1773548
Journal Information:
Scientific Reports, Journal Name: Scientific Reports Journal Issue: 1 Vol. 11; ISSN 2045-2322
Publisher:
Nature Publishing GroupCopyright Statement
Country of Publication:
United Kingdom
Language:
English

References (94)

Interaction of the anticancer agent Taxol? (paclitaxel) with phospholipid bilayers journal August 1999
Neovascular targeting chemotherapy: Encapsulation of paclitaxel in cationic liposomes impairs functional tumor microvasculature journal January 2004
Tumor-selective vessel occlusions by platelets after vascular targeting chemotherapy using paclitaxel encapsulated in cationic liposomes: Targeted Tumor-Selective Thromboses In Vivo journal October 2007
Vascular targeting by EndoTAG™-1 enhances therapeutic efficacy of conventional chemotherapy in lung and pancreatic cancer: Efficient Antitumoral Therapy by EndoTAG™-1 journal August 2009
Influence of cationic lipids on the stability and membrane properties of paclitaxel‐containing liposomes
  • Campbell, Robert B.; Balasubramanian, Sathyamangalam V.; Straubinger, Robert M.
  • Journal of Pharmaceutical Sciences, Vol. 90, Issue 8 https://doi.org/10.1002/jps.1063
journal August 2001
Fighting Cancer: From the Bench to Bedside Using Second Generation Cationic Liposomal Therapeutics journal February 2009
Liposomes with high encapsulation capacity for paclitaxel: Preparation, characterisation and in vivo anticancer effect**Štěpán Koudelka and Pavlína Turánek-Knötigová contributed equally to this work. journal May 2010
Characterization of Cationic Liposome Formulations Designed to Exhibit Extended Plasma Residence Times and Tumor Vasculature Targeting Properties journal June 2010
Weekly paclitaxel as second-line chemotherapy for advanced or recurrent gastric cancer journal February 2006
Paclitaxel chemotherapy for the treatment of gastric cancer journal June 2009
Antitumor Effect of Paclitaxel-Loaded PEGylated Immunoliposomes Against Human Breast Cancer Cells journal September 2007
Lipid nanoparticle delivery systems for siRNA-based therapeutics journal June 2013
Patisiran: First Global Approval journal September 2018
Interactions of mammalian cells with lipid dispersions containing novel metabolizable cationic amphiphiles journal March 1990
Paclitaxel-liposomes for intracavitary therapy of intraperitoneal P388 leukemia journal October 1996
Structure and design of polymeric surfactant-based drug delivery systems journal June 2001
Cremophor EL journal September 2001
Liposomal drug delivery systems: From concept to clinical applications journal January 2013
Preclinical and clinical development of siRNA-based therapeutics journal June 2015
Delivery of oligonucleotides with lipid nanoparticles journal June 2015
Co-delivery of drugs and plasmid DNA for cancer therapy journal March 2016
The battle of “nano” paclitaxel journal December 2017
Remote loading of doxorubicin into liposomes driven by a transmembrane phosphate gradient journal October 2006
The systemic toxicity of positively charged lipid nanoparticles and the role of Toll-like receptor 4 in immune activation journal September 2010
Distinct solubility and cytotoxicity regimes of paclitaxel-loaded cationic liposomes at low and high drug content revealed by kinetic phase behavior and cancer cell viability studies journal November 2017
Synthesis of linear and cyclic peptide–PEG–lipids for stabilization and targeting of cationic liposome–DNA complexes journal March 2016
A critical review of lipid-based nanoparticles for taxane delivery journal July 2013
Nanoparticle-siRNA: A potential cancer therapy? journal February 2016
Development and characterization of a novel Cremophor® EL free liposome-based paclitaxel (LEP-ETU) formulation journal January 2005
Enhanced solubility and stability of PEGylated liposomal paclitaxel: In vitro and in vivo evaluation journal June 2007
Paclitaxel: What has been done and the challenges remain ahead journal June 2017
Preparation and evaluation of paclitaxel-loaded PEGylated immunoliposome journal July 2007
Non-viral is superior to viral gene delivery journal November 2007
Improvement of drug safety by the use of lipid-based nanocarriers journal October 2012
Liposomal paclitaxel formulations journal November 2012
Non-viral gene therapy: Gains and challenges of non-invasive administration methods journal October 2016
Preclinical development of drug delivery systems for paclitaxel-based cancer chemotherapy journal December 2017
RNAi and small interfering RNAs in human disease therapeutic applications journal November 2010
Paclitaxel Crystal Seeds with Different Intrinsic Properties and Their Impact on Dissolution of Paclitaxel-HPMCAS Amorphous Solid Dispersions journal February 2018
Vectorization of Nucleic Acids for Therapeutic Approach: Tutorial Review journal March 2016
Formation of Highly Structured Cubic Micellar Lipid Nanoparticles of Soy Phosphatidylcholine and Glycerol Dioleate and Their Degradation by Triacylglycerol Lipase journal May 2014
Recent Advances in Nonviral Vectors for Gene Delivery journal August 2011
Taxol-Lipid Interactions: Taxol-Dependent Effects on the Physical Properties of Model Membranes journal August 1994
Plant antitumor agents. VI. Isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia journal May 1971
A Columnar Phase of Dendritic Lipid−Based Cationic Liposome−DNA Complexes for Gene Delivery:  Hexagonally Ordered Cylindrical Micelles Embedded in a DNA Honeycomb Lattice journal March 2006
Highly Efficient Gene Silencing Activity of siRNA Embedded in a Nanostructured Gyroid Cubic Lipid Matrix journal December 2010
Emerging Frontiers in Drug Delivery journal January 2016
Nanogyroids Incorporating Multivalent Lipids: Enhanced Membrane Charge Density and Pore Forming Ability for Gene Silencing journal June 2011
Mechanism of Macromolecular Structure Evolution in Self-Assembled Lipid Nanoparticles for siRNA Delivery journal April 2014
Promotion of microtubule assembly in vitro by taxol journal February 1979
Liposomes derived from molecular vases journal September 2012
Nanotechnologies in delivery of mRNA therapeutics using nonviral vector-based delivery systems journal January 2017
Microtubules as a target for anticancer drugs journal April 2004
RNA interference in the clinic: challenges and future directions journal December 2010
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases journal February 2017
Delivery technologies for genome editing journal March 2017
Recent advances with liposomes as pharmaceutical carriers journal February 2005
Non-viral vectors for gene-based therapy journal July 2014
Progress and challenges towards targeted delivery of cancer therapeutics journal April 2018
Cationic liposome–nucleic acid complexes for gene delivery and gene silencing journal January 2014
Paclitaxel Encapsulated in Cationic Liposomes Diminishes Tumor Angiogenesis and Melanoma Growth in a “Humanized” SCID Mouse Model journal March 2003
Paclitaxel (Taxol) journal April 1995
Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations. journal October 1993
Taxol Suppresses Dynamics of Individual Microtubules in Living Human Tumor Cells journal April 1999
How Taxol/paclitaxel kills cancer cells journal September 2014
Vascular and pharmacokinetic effects of EndoTAG-1 in patients with advanced cancer and liver metastasis journal April 2012
A randomized controlled phase II trial of a novel composition of paclitaxel embedded into neutral and cationic lipids targeting tumor endothelial cells in advanced triple-negative breast cancer (TNBC) journal April 2014
A randomized, controlled phase III trial of nab-Paclitaxel versus dacarbazine in chemotherapy-naïve patients with metastatic melanoma journal November 2015
Polyunsaturated Fatty Acid-Induced Cytotoxicity Against Tumor Cells and Its Relationship to Lipid Peroxidation journal April 1988
Cationic liposome–nucleic acid nanoparticle assemblies with applications in gene delivery and gene silencing
  • Majzoub, Ramsey N.; Ewert, Kai K.; Safinya, Cyrus R.
  • Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences, Vol. 374, Issue 2072 https://doi.org/10.1098/rsta.2015.0129
journal July 2016
Two-Dimensional Smectic Ordering of Linear DNA Chains in Self-Assembled DNA-Cationic Liposome Mixtures journal September 1997
Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come journal May 2016
Structure of DNA-Cationic Liposome Complexes: DNA Intercalation in Multilamellar Membranes in Distinct Interhelical Packing Regimes journal February 1997
An Inverted Hexagonal Phase of Cationic Liposome-DNA Complexes Related to DNA Release and Delivery journal July 1998
A Liposomal Formulation Able to Incorporate a High Content of Paclitaxel and Exert Promising Anticancer Effect journal October 2011
Cationic liposomes target angiogenic endothelial cells in tumors and chronic inflammation in mice. journal April 1998
Pharmacology and Toxicology of Cremophor EL Diluent journal May 1994
Abraxane® versus Taxol® for patients with advanced breast cancer: A prospective time and motion analysis from a Chinese health care perspective journal October 2014
Hypersensitivity reactions from taxol. journal July 1990
Phase III Trial of Nanoparticle Albumin-Bound Paclitaxel Compared With Polyethylated Castor Oil–Based Paclitaxel in Women With Breast Cancer journal November 2005
Randomized Phase III Trial of Paclitaxel Once Per Week Compared With Nanoparticle Albumin-Bound Nab-Paclitaxel Once Per Week or Ixabepilone With Bevacizumab As First-Line Chemotherapy for Locally Recurrent or Metastatic Breast Cancer: CALGB 40502/NCCTG N063H (Alliance) journal July 2015
Pharmacokinetics of paclitaxel-containing liposomes in rats journal December 2003
Paclitaxel in cancer therapy journal June 2002
Paclitaxel for non-small cell lung cancer journal August 2004
Cationic lipid–DNA complexes for non-viral gene therapy: relating supramolecular structures to cellular pathways journal January 2005
Challenges in the pharmaceutical development of lipid-based short interfering ribonucleic acid therapeutics journal January 2012
Endometrial Carcinoma: A Review of Chemotherapy, Drug Resistance, and the Search for New Agents journal October 2010
Development of paclitaxel-loaded liposomal nanocarrier stabilized by triglyceride incorporation journal January 2016
Docosahexaenoic acid liposomes for targeting chronic inflammatory diseases and cancer: an in vitro assessment journal January 2016
Optimization of drug loading to improve physical stability of paclitaxel-loaded long-circulating liposomes journal December 2014
Advances and Challenges of Liposome Assisted Drug Delivery journal December 2015
Liposomal paclitaxel induces fewer hematopoietic and cardiovascular complications than bioequivalent doses of Taxol journal June 2018
Paclitaxel Nano-Delivery Systems: A Comprehensive Review journal January 2013
Designing Paclitaxel Drug Delivery Systems Aimed at Improved Patient Outcomes: Current Status and Challenges journal August 2012